Discovery of a novel immune gene signature with profound prognostic value in colorectal cancer: A model of cooperativity disorientation created in the process from development to cancer

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  An, Ning ^a   Shi, Xiaoyu ^a   Zhang, Yueming ^b   Lv, Ning ^b   Feng, Lin ^a   Di, Xuebing ^a   Han, Naijun ^a   Wang, Guiqi ^b   Cheng, Shujun ^a   Zhang, Kaitai ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL FUNCTION; COLORECTAL CANCER; CONTROLLED STUDY; COOPERATION; DISEASE FREE SURVIVAL; DISORIENTATION; EMBRYO DEVELOPMENT; FEMALE; GENETIC HETEROGENEITY; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; KAPLAN MEIER METHOD; MACHINE LEARNING; MAJOR CLINICAL STUDY; MALE; MOLECULAR MECHANICS; OVERALL SURVIVAL; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; IMMUNOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SURVIVAL ANALYSIS; VALIDATION STUDY;

AGED; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 84943327668     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137171     Document Type: Article

References (68)

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86. Epub 2014/09/16. doi: 10.1002/ijc.29210 PMID: 25220842.
2. Brenner H, Kloor M, Pox CP. Colorectal cancer. Lancet. 2014;383(9927):1490-502. Epub 2013/11/15. doi: 10.1016/S0140-6736 (13) 61649-9 PMID: 24225001.
3. Kanthan R, Senger JL, Kanthan SC. Molecular events in primary and metastatic colorectal carcinoma: a review. Patholog Res Int. 2012;2012:597497. Epub 2012/09/22. doi: 10.1155/2012/597497 PMID: 22997602; PubMed Central PMCID: PMC3357597.
4. Troiani T, Martinelli E, Napolitano S, Morgillo F, Belli G, Cioffi L, et al. Molecular aspects of resistance to biological and non-biological drugs and strategies to overcome resistance in colorectal cancer. Curr Med Chem. 2014;21(14):1639-53. Epub 2013/09/03. PMID: 23992332.
5. Schlicker A, Beran G, Chresta CM, McWalter G, Pritchard A, Weston S, et al. Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines. BMC Med Genomics. 2012;5:66. Epub 2013/01/01. doi: 10.1186/1755-8794-5-66 PMID: 23272949; PubMed Central PMCID: PMC3543849.
6. Jeng KS, Chang CF, Jeng WJ, Sheen IS, Jeng CJ. Heterogeneity of hepatocellular carcinoma contributes to cancer progression. Crit Rev Oncol Hematol. 2015. Epub 2015/02/15. doi: 10.1016/j.critrevonc. 2015.01.009 PMID: 25680939.
7. Skibinski A, Kuperwasser C. The origin of breast tumor heterogeneity. Oncogene. 2015. Epub 2015/02/24. doi: 10.1038/onc.2014.475 PMID: 25703331.
8. Cheng X, Chen H. Tumor heterogeneity and resistance to EGFR-targeted therapy in advanced nonsmall cell lung cancer: challenges and perspectives. Onco Targets Ther. 2014;7:1689-704. Epub 2014/10/07. doi: 10.2147/OTT. S66502 PMID: 25285017; PubMed Central PMCID: PMC4181629.
9. Burrell RA, McGranahan N, Bartek J, Swanton C. The causes and consequences of genetic heterogeneity in cancer evolution. Nature. 2013;501(7467):338-45. Epub 2013/09/21. doi: 10.1038/nature12625 PMID: 24048066.
10. Xie K, Abbruzzese JL. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell. 2003;4(4):245-7. Epub 2003/10/31. PMID: 14585350.
11. Kho AT, Zhao Q, Cai Z, Butte AJ, Kim JY, Pomeroy SL, et al. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev. 2004;18(6):629-40. Epub 2004/04/13. doi: 10.1101/gad.1182504 PMID: 15075291; PubMed Central PMCID: PMC387239.
12. Liu HY, Kho AT, Kohane IS, Sun Y. Predicting survival within the lung cancer histopathological hierarchy using a multi-scale genomic model of development. Plos Medicine. 2006;3(7):1090-102. doi: Artn E232 doi: 10.1371/Journal. Pmed.0030232 ISI:000239493300028.
13. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007;8(7):R131. Epub 2007/07/07. doi: 10.1186/gb-2007-8-7-r131 PMID: 17615082; PubMed Central PMCID: PMC2323222.
14. Nieto MA. Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells. Science. 2013;342(6159):708-+. doi: 10.1126/science.1234850 ISI:000326647600033.
15. Eastham AM, Spencer H, Soncin F, Ritson S, Merry CLR, Stern PL, et al. Epithelial-mesenchymal transition events during human embryonic stem cell differentiation. Cancer Res. 2007;67(23):11254-62. doi: 10.1158/0008-5472. Can-07-2253 ISI:000251444100023. PMID: 18056451
16. Ridolfi L, Petrini M, Fiammenghi L, Riccobon A, Ridolfi R. Human embryo immune escape mechanisms rediscovered by the tumor. Immunobiology. 2009;214(1):61-76. doi: 10.1016/j.imbio.2008.03.003 ISI:000263689600007. PMID: 19159828
17. Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105-11. PMID: 11689955
18. Chen Y, Mcgee J, Chen XM, Doman TN, Gong XQ, Zhang YY, et al. Identification of Druggable Cancer Driver Genes Amplified across TCGA Datasets. Plos One. 2014;9 (5). doi: ARTN e98293 doi: 10.1371/journal.pone.0098293 ISI:000336790800032.
19. Bockmayr M, Klauschen F, Gyorffy B, Denkert C, Budczies J. New network topology approaches reveal differential correlation patterns in breast cancer. Bmc Systems Biology. 2013;7. doi: Artn 78 doi: 10. 1186/1752-0509-7-78 ISI:000324816800001.
20. Teschendorff AE, Gomez S, Arenas A, El-Ashry D, Schmidt M, Gehrmann M, et al. Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modules. Bmc Cancer. 2010;10. doi: Artn 604 doi: 10.1186/1471-2407-10-604 ISI:000284575500001.
21. Bagga S, Bracht J, Hunter S, Massirer K, Holtz J, Eachus R, et al. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell. 2005;122(4):553-63. doi: 10.1016/j.cell.2005.07.031 ISI:000231555100011. PMID: 16122423
22. Friedman RC, Farh KKH, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Research. 2009;19(1):92-105. doi: 10.1101/gr.082701.108 ISI:000262200000009. PMID: 18955434
23. Shukla GC, Singh J, Barik S. MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol. 2011;3(3):83-92. Epub 2011/01/01. PMID: 22468167; PubMed Central PMCID: PMC3315687.
24. Ghildiyal M, Zamore PD. Small silencing RNAs: an expanding universe. Nature Reviews Genetics. 2009;10(2):94-108. doi: 10.1038/Nrg2504 ISI:000263091500011. PMID: 19148191
25. Yang D, Sun Y, Hu L, Zheng H, Ji P, Pecot CV, et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell. 2013;23(2):186-99. Epub 2013/02/16. doi: 10.1016/j.ccr.2012.12.020 PMID: 23410973; PubMed Central PMCID: PMC3603369.
26. Hanahan D, Weinberg RA. Hallmarks of Cancer: The Next Generation. Cell. 2011;144(5):646-74. doi: 10.1016/j.cell.2011.02.013 ISI:000288007100007. PMID: 21376230
27. Montgomery RK, Mulberg AE, Grand RJ. Development of the human gastrointestinal tract: twenty years of progress. Gastroenterology. 1999;116(3):702-31. Epub 1999/02/25. PMID: 10029630.
28. Stolte M. The new Vienna classification of epithelial neoplasia of the gastrointestinal tract: advantages and disadvantages. Virchows Archiv. 2003;442(2):99-106. PMID: 12596058
29. Davila RE, Rajan E, Adler D, Hirota WK, Jacobson BC, Leighton JA, et al. ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. Gastrointestinal endoscopy. 2005;61(1):1-7. PMID: 15672048
30. Griffiths-Jones S, Grocock RJ, Van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34(Database issue):D140-4. Epub 2005/12/31. doi: 10.1093/nar/gkj112 PMID: 16381832; PubMed Central PMCID: PMC1347474.
31. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell. 2007;27(1):91-105. Epub 2007/07/07. doi: 10.1016/j.molcel.2007.06.017 PMID: 17612493; PubMed Central PMCID: PMC3800283.
32. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, et al. Combinatorial microRNA target predictions. Nat Genet. 2005;37(5):495-500. Epub 2005/04/05. doi: 10.1038/ng1536 PMID: 15806104.
33. Calle ML, Urrea V, Boulesteix AL, Malats N. AUC-RF: a new strategy for genomic profiling with random forest. Hum Hered. 2011;72(2):121-32. Epub 2011/10/15. doi: 10.1159/000330778 PMID: 21996641.
34. Liaw A, Wiener M. Classification and Regression by randomForest. R news. 2002;2(3):18-22.
35. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC bioinformatics. 2011;12(1):77.
36. Carlson M.org. Hs. eg. db: Genome wide annotation for Human. R package version; 2013.
37. Killcoyne S, Carter GW, Smith J, Boyle J. Cytoscape: a community-based framework for network modeling. Methods Mol Biol. 2009;563:219-39. Epub 2009/07/15. doi: 10.1007/978-1-60761-175-2-12 PMID: 19597788.
38. Hartwell KA, Muir B, Reinhardt F, Carpenter AE, Sgroi DC, Weinberg RA. The Spemann organizer gene, Goosecoid, promotes tumor metastasis. Proceedings of the National Academy of Sciences of the United States of America. 2006;103(50):18969-74. doi: 10.1073/pnas.0608636103 ISI:000242884200019. PMID: 17142318
39. Sparmann A, Van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nature Reviews Cancer. 2006;6(11):846-56. doi: 10.1038/Nrcd1991 ISI:000241493800009. PMID: 17060944
40. Liu SL, Dontu G, Mantle ID, Patel S, Ahn NS, Jackson KW, et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Research. 2006;66(12):6063-71. doi: 10.1158/0008-5472. Can-06-0054 ISI:000238379500015. PMID: 16778178
41. Kang HC, Wakabayashi Y, Jen KY, Mao JH, Zoumpourlis V, Del Rosario R, et al. Ptch1 overexpression drives skin carcinogenesis and developmental defects in K14Ptch (FVB) mice. J Invest Dermatol. 2013;133(5):1311-20. Epub 2012/12/12. doi: 10.1038/jid.2012.419 PMID: 23223138; PubMed Central PMCID: PMC3610826.
42. Kho AT, Zhao Q, Cai ZH, Butte AJ, Kim JYH, Pomeroy SL, et al. Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes & Development. 2004;18(6):629-40. doi: 10.1101/Gad.1182504 ISI:000220794200005.
43. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, et al. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biol. 2007;8 (7). doi: Artn R131 doi: 10.1186/Gb-2007-8-7-R131 ISI:000249416400011.
44. Hu H, Zhou L, Awadallah A, Xin W. Significance of Notch1-signaling pathway in human pancreatic development and carcinogenesis. Appl Immunohistochem Mol Morphol. 2013;21(3):242-7. Epub 2012/12/14. doi: 10.1097/PAI.0b013e3182655ab7 PMID: 23235341.
45. Greaves M, Maley CC. Clonal evolution in cancer. Nature. 2012;481(7381):306-13. Epub 2012/01/20. doi: 10.1038/nature10762 PMID: 22258609; PubMed Central PMCID: PMC3367003.
46. Watson IR, Takahashi K, Futreal PA, Chin L. Emerging patterns of somatic mutations in cancer. Nat Rev Genet. 2013;14(10):703-18. Epub 2013/09/12. doi: 10.1038/nrg3539 PMID: 24022702.
47. Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science. 2011;331(6024):1553-8. Epub 2011/03/26. doi: 10.1126/science.1204040 PMID: 21436442.
48. Wicha MS, Liu SL, Dontu G. Cancer stem cells: An old idea-A paradigm shift. Cancer Res. 2006;66(4):1883-90. doi: 10.1158/0008-5472. Can-05-3153 ISI:000235387200001. PMID: 16488983
49. Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer. 2007;121(11):2373-80. Epub 2007/09/26. doi: 10.1002/ijc.23173 PMID: 17893866.
50. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436-44. Epub 2008/07/25. doi: 10.1038/nature07205 PMID: 18650914.
51. Bruttel VS, Wischhusen J. Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape? Front Immunol. 2014;5:360. Epub 2014/08/15. doi: 10.3389/fimmu.2014. 00360 PMID: 25120546; PubMed Central PMCID: PMC4114188.
52. Ulrich C, Schmook T, Sachse MM, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg. 2004;30(4 Pt 2):622-7. Epub 2004/04/06. doi: 10.1111/j.1524-4725.2004.30147.x PMID: 15061846.
53. Andres A. Cancer incidence after immunosuppressive treatment following kidney transplantation. Crit Rev Oncol Hematol. 2005;56(1):71-85. Epub 2005/06/28. doi: 10.1016/j.critrevonc.2004.11.010 PMID: 15978827.
54. Bower M, Palmieri C, Dhillon T. AIDS-related malignancies: changing epidemiology and the impact of highly active antiretroviral therapy. Current Opinion in Infectious Diseases. 2006;19(1):14-9. doi: 10. 1097/01.qco.0000200295.30285.13 ISI:000235095300003. PMID: 16374212
55. Dal Maso L, Serraino D, Franceschi S. Epidemiology of AIDS-related tumours in developed and developing countries. European Journal of Cancer. 2001;37(10):1188-201. doi: 10.1016/S0959-8049 (01) 00120-4 ISI:000169648500003. PMID: 11423251
56. Farraye FA, Odze RD, Eaden J, Itzkowitz SH. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology. 2010;138(2):746-74, 74 e1-4; quiz e12-3. Epub 2010/02/10. doi: 10.1053/j.gastro.2009.12.035 PMID: 20141809.
57. Chen GY, Nunez G. Inflammasomes in intestinal inflammation and cancer. Gastroenterology. 2011;141(6):1986-99. Epub 2011/10/19. doi: 10.1053/j.gastro.2011.10.002 PMID: 22005480; PubMed Central PMCID: PMC3442608.
58. Boysen J, Sinha S, Price-Troska T, Warner SL, Bearss DJ, Viswanatha D, et al. The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients. Leukemia. 2014;28(2):451-5. Epub 2013/11/13. doi: 10.1038/leu. 2013.298 PMID: 24217154; PubMed Central PMCID: PMC3929965.
59. Mudduluru G, Ceppi P, Kumarswamy R, Scagliotti GV, Papotti M, Allgayer H. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene. 2011;30(25):2888-99. Epub 2011/02/15. doi: 10.1038/onc.2011.13 PMID: 21317930.
60. Dunne PD, Mcart DG, Blayney JK, Kalimutho M, Greer S, Wang TT, et al. AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer. Clinical Cancer Research. 2014;20(1):164-75. doi: 10.1158/1078-0432. Ccr-13-1354 ISI:000329303100019. PMID: 24170546
61. Mees ST, Mardin WA, Wendel C, Baeumer N, Willscher E, Senninger N, et al. EP300-a miRNA-regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas. Int J Cancer. 2010;126(1):114-24. Epub 2009/07/02. doi: 10.1002/ijc.24695 PMID: 19569050.
62. Kim MS, Lee SH, Yoo NJ. Frameshift mutations of tumor suppressor gene EP300 in gastric and colorectal cancers with high microsatellite instability. Hum Pathol. 2013;44(10):2064-70. Epub 2013/06/14. doi: 10.1016/j.humpath.2012.11.027 PMID: 23759652.
63. Pham TT, Angus SP, Johnson GL. MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis. Genes Cancer. 2013;4(11-12):419-26. Epub 2014/01/05. doi: 10.1177/1947601913513950 PMID: 24386504; PubMed Central PMCID: PMC3877667.
64. Shang J, Yang F, Wang Y, Wang Y, Xue G, Mei Q, et al. MicroRNA-23a Antisense Enhances 5-Fluorouracil Chemosensitivity Through APAF-1/Caspase-9 Apoptotic Pathway in Colorectal Cancer Cells. J Cell Biochem. 2014;115(4):772-84. doi: 10.1002/jcb.24721 PMID: 24249161
65. Yong FL, Law CW, Wang CW. Potentiality of a triple microRNA classifier: miR-193a-3p, miR-23a and miR-338-5p for early detection of colorectal cancer. BMC Cancer. 2013;13:280. Epub 2013/06/14. doi: 10.1186/1471-2407-13-280 PMID: 23758639; PubMed Central PMCID: PMC3691634.
66. Yamaguchi T, Iijima T, Wakaume R, Takahashi K, Matsumoto H, Nakano D, et al. Underexpression of miR-126 and miR-20b in Hereditary and Nonhereditary Colorectal Tumors. Oncology. 2014;87(1):58-66. doi: 10.1159/000363303 ISI:000338974700007. PMID: 24994098
67. Fang LK, Li HR, Wang L, Hu J, Jin TR, Wang JP, et al. MicroRNA-17-5p promotes chemotherapeutic drug resistance and tumour metastasis of colorectal cancer by repressing PTEN expression. Oncotarget. 2014;5(10):2974-87. ISI:000336967000009. PMID: 24912422
68. Ma YL, Zhang P, Wang F, Zhang HZ, Yang YZ, Shi CZ, et al. Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nature Communications. 2012;3. doi: Artn 1291 doi: 10.1038/Ncomms2276 ISI:000316356700058.